Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Nurix Therapeutics (NRIX) Return on Assets: 2020-2025

Historic Return on Assets for Nurix Therapeutics (NRIX) over the last 5 years, with Aug 2025 value amounting to -0.44%.

  • Nurix Therapeutics' Return on Assets fell 9.00% to -0.44% in Q3 2025 from the same period last year, while for Aug 2025 it was -0.44%, marking a year-over-year decrease of 9.00%. This contributed to the annual value of -0.38% for FY2024, which is negligibly% changed negligibly from last year.
  • Latest data reveals that Nurix Therapeutics reported Return on Assets of -0.44% as of Q3 2025, which was down 27.88% from -0.34% recorded in Q2 2025.
  • Nurix Therapeutics' Return on Assets' 5-year high stood at -0.14% during Q1 2021, with a 5-year trough of -0.45% in Q1 2023.
  • Moreover, its 3-year median value for Return on Assets was -0.43% (2024), whereas its average is -0.40%.
  • Its Return on Assets has fluctuated over the past 5 years, first fell by 20bps in 2022, then climbed by 11bps in 2024.
  • Over the past 5 years, Nurix Therapeutics' Return on Assets (Quarterly) stood at -0.24% in 2021, then decreased by 17bps to -0.41% in 2022, then dropped by 2bps to -0.43% in 2023, then increased by 11bps to -0.33% in 2024, then fell by 9bps to -0.44% in 2025.
  • Its Return on Assets stands at -0.44% for Q3 2025, versus -0.34% for Q2 2025 and -0.32% for Q1 2025.